LGALS3 and heart failure: The prognostic accuracy of sST2 is comparable in both heart failure with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF), and it outperforms Galectin-3 (Gal-3) in patients with chronic heart failure.